22 January 2024
| Title | Language | Date |
|---|---|---|
| No title | Dutch | 22-01-2024 |
| No title | Dutch | 22-01-2024 |
| No title | Dutch | 22-01-2024 |
| No title | Dutch | 22-01-2024 |
| No title | Dutch | 22-01-2024 |
| No title | Dutch | 22-01-2024 |
| No title | Dutch | 22-01-2024 |
| No title | Dutch | 22-01-2024 |
| No title | Dutch | 22-01-2024 |
| No title | Dutch | 22-01-2024 |
| No title | Dutch | 22-01-2024 |
| No title | Dutch | 22-01-2024 |
| No title | Dutch | 22-01-2024 |
| No title | Dutch | 22-01-2024 |
| No title | Dutch | 22-01-2024 |
| No title | Dutch | 22-01-2024 |
| No title | Dutch | 22-01-2024 |
| No title | Dutch | 22-01-2024 |
| Beslissing tot onderwerping van de uitvoer van het geneesmiddel Oncotice i.vesic. susp. (pdr.) bestemd voor de Belgische markt aan een voorafgaande toelating | Dutch | 22-01-2024 |
| No title | Dutch | 22-01-2024 |
